Borucki K - Search Results

1

Extended-release niacin raises adiponectin and leptin.

Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Westphal S, et al. Among authors: borucki k. Atherosclerosis. 2007 Aug;193(2):361-5. doi: 10.1016/j.atherosclerosis.2006.06.028. Epub 2006 Aug 2. Atherosclerosis. 2007. PMID: 16887123 Clinical Trial.

2

Treatment with niacin lowers ADMA.

Westphal S, Borucki K, Luley C, Martens-Lobenhoffer J, Bode-Böger SM. Westphal S, et al. Among authors: borucki k. Atherosclerosis. 2006 Feb;184(2):448-50. doi: 10.1016/j.atherosclerosis.2005.11.018. Epub 2005 Dec 22. Atherosclerosis. 2006. PMID: 16376893 No abstract available.

3

Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.

Taneva E, Borucki K, Wiens L, Makarova R, Schmidt-Lucke C, Luley C, Westphal S. Taneva E, et al. Among authors: borucki k. Am J Cardiol. 2006 Apr 1;97(7):1002-6. doi: 10.1016/j.amjcard.2005.10.032. Epub 2006 Feb 13. Am J Cardiol. 2006. PMID: 16563905 Clinical Trial.

4

Adipokines and treatment with niacin.

Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Westphal S, et al. Among authors: borucki k. Metabolism. 2006 Oct;55(10):1283-5. doi: 10.1016/j.metabol.2006.07.002. Metabolism. 2006. PMID: 16979396

5

Addition of 2.5 g L-arginine in a fatty meal prevents the lipemia-induced endothelial dysfunction in healthy volunteers.

Borucki K, Aronica S, Starke I, Luley C, Westphal S. Borucki K, et al. Atherosclerosis. 2009 Jul;205(1):251-4. doi: 10.1016/j.atherosclerosis.2008.10.026. Epub 2008 Nov 6. Atherosclerosis. 2009. PMID: 19081092

6

B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.

Heinz J, Kropf S, Domröse U, Westphal S, Borucki K, Luley C, Neumann KH, Dierkes J. Heinz J, et al. Among authors: borucki k. Circulation. 2010 Mar 30;121(12):1432-8. doi: 10.1161/CIRCULATIONAHA.109.904672. Epub 2010 Mar 15. Circulation. 2010. PMID: 20231532 Clinical Trial.

7

Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.

Grenkowitz T, Kassner U, Wühle-Demuth M, Salewsky B, Rosada A, Zemojtel T, Hopfenmüller W, Isermann B, Borucki K, Heigl F, Laufs U, Wagner S, Kleber ME, Binner P, März W, Steinhagen-Thiessen E, Demuth I. Grenkowitz T, et al. Among authors: borucki k. Atherosclerosis. 2016 Oct;253:88-93. doi: 10.1016/j.atherosclerosis.2016.08.037. Epub 2016 Aug 26. Atherosclerosis. 2016. PMID: 27596133

8

Detection of recent ethanol intake with new markers: comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5-hydroxyindole acetic acid in urine.

Borucki K, Schreiner R, Dierkes J, Jachau K, Krause D, Westphal S, Wurst FM, Luley C, Schmidt-Gayk H. Borucki K, et al. Alcohol Clin Exp Res. 2005 May;29(5):781-7. doi: 10.1097/01.alc.0000164372.67018.ea. Alcohol Clin Exp Res. 2005. PMID: 15897723 Clinical Trial.

9

In heavy drinkers, fatty acid ethyl esters remain elevated for up to 99 hours.

Borucki K, Dierkes J, Wartberg J, Westphal S, Genz A, Luley C. Borucki K, et al. Alcohol Clin Exp Res. 2007 Mar;31(3):423-7. doi: 10.1111/j.1530-0277.2006.00323.x. Alcohol Clin Exp Res. 2007. PMID: 17295726

10

In heavy drinkers fatty acid ethyl esters in the serum are increased for 44 hr after ethanol consumption.

Borucki K, Kunstmann S, Dierkes J, Westphal S, Diekmann S, Bogerts B, Luley C. Borucki K, et al. Alcohol Clin Exp Res. 2004 Jul;28(7):1102-6. doi: 10.1097/01.alc.0000130791.20186.4d. Alcohol Clin Exp Res. 2004. PMID: 15252297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results